| Market Capitalization (Millions $) |
32 |
| Shares
Outstanding (Millions) |
29 |
| Employees |
105 |
| Revenues (TTM) (Millions $) |
1 |
| Net Income (TTM) (Millions $) |
-57 |
| Cash Flow (TTM) (Millions $) |
-2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc is a clinical-stage bio-pharmaceutical company founded in 2012 and headquartered in San Jose, California. The company's core mission is to develop innovative, non-injectable therapies that can be administered orally.
Rani Therapeutics' flagship product is the RaniPill capsule, which is a self-administered drug delivery device designed to replace injections. The RaniPill is packed with tiny needles that are typically made of sugar and dissolve when the capsule is swallowed. When the capsule reaches the stomach, it is designed to inject the medication directly into the intestinal wall where it is absorbed into the bloodstream.
The company is focused on developing oral formulations of large-molecule biologics, such as complex proteins and peptides, which traditionally have to be administered by injection. With its innovative technology, Rani Therapeutics is hoping to change the way medication is delivered, making it easier for patients to receive lifesaving treatment without having to endure painful and inconvenient injections.
In addition to the RaniPill, the company is also developing a range of other novel drug delivery systems, including the RaniNose nasal spray and the RaniPatch transdermal patch.
Rani Therapeutics has received significant financial backing from numerous venture capitalists, including 5AM Ventures, Novartis, and GV (formerly known as Google Ventures). The company has raised more than $142 million to date.
Rani Therapeutics' experienced management team includes highly qualified industry professionals who have a track record of developing and commercializing innovative pharmaceutical products. The company employs over 80 people across its research and development, manufacturing, and business development teams.
Overall, Rani Therapeutics Holdings Inc is a dynamic and growing company that is at the forefront of developing innovative, non-injectable therapies that have the potential to transform the treatment of a range of medical conditions.
Company Address: 2051 Ringwood Avenue San Jose 95131 CA
Company Phone Number: 457-3700 Stock Exchange / Ticker: NASDAQ RANI
|
0.85%